TAO Synergies (TAOX) Other Working Capital Changes (2023 - 2026)
TAO Synergies' (TAOX) quarterly Other Working Capital Changes came in at $1697.0 in Q2 2026, up 100.83% on a YoY basis from $845.0 in Q2 2025, and up 100.33% quarter-over-quarter from -$516429.0 in Q1 2026.
Analysis
TAO Synergies (TAOX) Other Working Capital Changes (2023 - 2026) Analysis & Trends
TAO Synergies (TAOX) has reported Other Working Capital Changes for 4 consecutive years, with $1697.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Working Capital Changes rose 100.83% year-over-year to $1697.0; the trailing twelve-month figure through Jun 2026 stood at -$349327.0 (down 164.45% YoY), and the FY2025 full-year result was $379826.0, up 203.18% from the prior year.
- Other Working Capital Changes climbed to $1697.0 in Q2 2026 per TAOX's latest filing, from -$516429.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $419520.0 in Q1 2025 and bottomed at -$516429.0 in Q1 2026.
- Historically, Other Working Capital Changes has averaged -$84103.8 across 4 years, with a median of -$148015.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 306.36% in 2024, then jumped 281.86% in 2025.
- Over 4 years, Other Working Capital Changes stood at -$180432.0 in 2023, then grew by 18.75% to -$146597.0 in 2024, then surged by 281.86% to $266603.0 in 2025, then sank by 99.36% to $1697.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $1697.0, -$516429.0, and $266603.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn |
| 10 | TAO Synergies | 30.79 Mn | 30.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,697.00 |
| Jun 30, 2026 | 1,697.00 |
| Mar 31, 2026 | -516,429.00 |
| Mar 31, 2026 | -516,429.00 |
| Dec 31, 2025 | 266,603.00 |
| Dec 31, 2025 | 266,603.00 |
| Sep 30, 2025 | -101,198.00 |
| Sep 30, 2025 | -101,198.00 |
| Jun 30, 2025 | -205,099.00 |
| Jun 30, 2025 | -205,099.00 |
| Mar 31, 2025 | 419,520.00 |
| Mar 31, 2025 | 419,520.00 |
| Dec 31, 2024 | -146,597.00 |
| Dec 31, 2024 | -146,597.00 |
| Sep 30, 2024 | -199,919.00 |
| Sep 30, 2024 | -199,919.00 |
| Jun 30, 2024 | -149,433.00 |
| Jun 30, 2024 | -149,433.00 |
| Mar 31, 2024 | 127,821.00 |
| Mar 31, 2024 | 127,821.00 |